share_log

HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $10 Price Target

Benzinga ·  Jul 12 01:24

HC Wainwright & Co. analyst Emily Bodnar reiterates Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $10 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment